Latest papers

Research from anesthesiology, pain and critical care journals, sourced from PubMed.

Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.

AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.

Last successful paper check: 16 Nov 2026 17:18 UTC. 0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
Article Paediatr Anaesth Published 2 Sep 2026
Impact of Socioeconomic Deprivation on children's Need for Anesthesia: A Retrospective Analysis of Electronic Health Records From a Tertiary Referral children's Hospital.
AI-generated abstract summary · verify against the original paper
  • Retrospective cross-sectional analysis of electronic records from 71,613 anaesthetic episodes at a UK tertiary children's hospital, 2016–2024, linked to area deprivation data.
  • Exposure was area deprivation (IMD), and the outcome was the odds of presenting for a procedure requiring anaesthesia, analysed with mixed-effects logistic regression.
  • Children from deprived areas had higher adjusted odds of anaesthetic procedures (aOR 1.15, 95% CI 1.13–1.17, p<0.001), with the strongest effect for dental procedures and the most deprived deciles.
  • The authors report the association held across most specialities and in sensitivity analysis, and they call for preventive interventions to reduce child health inequalities.
PubMed indexed 3 Sep 2026 Imported 9 Nov 2026 Atandi B et al. Publisher Pediatric
Observational Anaesthesia Published 2 Sep 2026
Patient-reported outcomes, postoperative pain and pain relief after day-case surgery (POPPY): acute pain and recovery during the first 7 days.
AI-generated abstract summary · verify against the original paper
  • A national prospective observational study (POPPY) of UK day-case surgery patients, with 7839 recruited and 7331 responding on day 7.
  • No intervention was compared; the study examined patient and surgical characteristics associated with poor pain and functional outcomes over the first postoperative week.
  • A poor pain outcome (pain above 4/10) occurred in 1458/4348 (33.5%) patients, and pain impaired function in 1279/4854 (26.3%) at day 7.
  • The authors conclude recovery is incomplete for many patients by day 7, and they suggest identifying high-risk patients for better preparation and closer follow-up. Opioid-naive patients had lower odds of both poor outcomes.
PubMed indexed 3 Sep 2026 Everson M et al. Publisher
Article Reg Anesth Pain Med Published 2 Sep 2026
When gastric point-of-care ultrasound is indeterminate: an educational review and suggested reporting framework.
AI-generated abstract summary · verify against the original paper
  • This educational review is a focused secondary analysis of the 65 studies from an earlier narrative review of gastric POCUS in medically complex patients.
  • It examined how studies reported scans not performed, scans started but not completed, technically inadequate images, and uncertain results despite visualization.
  • Of the 65 studies, 32 reported at least one indeterminate or non-interpretable exam, 24 reported none, and nine were unclear or non-numeric.
  • The authors state that an indeterminate scan is non-diagnostic and should prompt reliance on the original aspiration-risk assessment or a more cautious plan.
PubMed indexed 2 Sep 2026 Imported 9 Nov 2026 Haskins SC et al. Publisher Regional
Article Anesth Analg Published 2 Sep 2026
BMI, Comorbidity Burden, and Postoperative Delirium in Older Adults: A Retrospective Cohort Study.
AI-generated abstract summary · verify against the original paper
  • Retrospective cohort of 4,320 adults aged 65 or older who had noncardiac, non-neurological surgery under general anesthesia (2015-2024), examining BMI and postoperative delirium within 7 days.
  • The exposure was BMI category, with Charlson Comorbidity Index dichotomized as low or high, tested for interaction in a prespecified multivariable logistic regression model.
  • In low-CCI patients, overweight (aOR 0.69, 0.53-0.90) and class 1 obesity (0.65, 0.46-0.92) were protective; high-CCI patients showed no BMI difference (interaction P = .040).
  • The authors conclude that the BMI-delirium relationship depends on comorbidity burden and that BMI should be interpreted alongside the CCI when assessing delirium risk.
PubMed indexed 2 Sep 2026 Imported 9 Nov 2026 Lee C et al. Publisher Neuro
Article Pain Med Published 2 Sep 2026
Does the National Resident Matching Program Rank List Predict Accreditation College of Graduate Medical Education Trainee Performance Among Multispecialty Pain Medicine Fellows? A Multicenter Study.
AI-generated abstract summary · verify against the original paper
  • This multicenter study of 93 fellows from 4 multispecialty pain medicine programs compared NRMP rank-list position with later performance on the ACGME core competencies.
  • Relative rank-list position was correlated with cohort-relative ACGME performance using Spearman correlation, permutation testing, and stratified bootstrap confidence intervals.
  • The overall correlation was not significant (Spearman r = 0.06; 95% CI, -0.19 to 0.32; p = 0.63), and sensitivity and domain-specific analyses were also nonsignificant.
  • Bottom-ranked fellows performed worse than top- and middle-ranked groups across domains, a weak signal the authors suggest may reflect flawed ranking or evaluation metrics.
PubMed indexed 2 Sep 2026 Imported 9 Nov 2026 Cohen SP et al. Publisher Chronic pain
RCT Paediatr Anaesth Published 2 Sep 2026
Up-and-Down Sequential Allocation Study Comparing the Median Effective Dose of Remimazolam Versus Propofol for Inducing Unconsciousness in Pediatric Patients.
AI-generated abstract summary · verify against the original paper
  • Randomized dose-finding trial using a Dixon up-and-down design in 50 children aged 2 to 14 years having elective surgery.
  • Children received a single intravenous bolus of remimazolam or propofol for induction, in two parallel dose-finding arms.
  • Remimazolam's ED50 for loss of consciousness was 0.17 mg/kg (95% CI 0.16-0.19) and its ED95 was 0.26 mg/kg (95% CI 0.23-0.29).
  • Heart rate was more stable with remimazolam, and no respiratory depression or hypotension occurred in either group.
PubMed indexed 2 Sep 2026 Imported 9 Nov 2026 Gu YL et al. Publisher PediatricPharmacology
Article Pain Published 2 Sep 2026
Deep FLASH-seq profiling of purified canine sensory neurons uncovers species-specific signatures relevant to pain and itch.
AI-generated abstract summary · verify against the original paper
  • This single-cell transcriptomic study profiled purified intact neurons from adult canine dorsal root ganglia using a new dissociation and sorting method with full-length FLASH-seq RNA sequencing.
  • The authors identified canine sensory neuron clusters matching conserved DRG organization and compared them with human and mouse DRG datasets.
  • Species-specific differences in subtype-restricted expression of IL31RA and SSTR2 were found and validated by in situ hybridization, with domestication-associated genes nonrandomly enriched in specific neurons.
  • The authors present the dataset as a resource for comparative sensory neuroscience and for interpreting pain and itch therapeutic targets across species.
PubMed indexed 2 Sep 2026 Imported 9 Nov 2026 Ledesma Fernandez P et al. Publisher Chronic pain
Review N Am Spine Soc J Published 1 Sep 2026
GLP-1 receptor agonists in elective spine surgery: a systematic review of fusion outcomes, perioperative safety, and procedure-specific risk.
AI-generated abstract summary · verify against the original paper
  • This systematic review qualitatively synthesized 23 studies, mostly retrospective cohorts and propensity-matched database analyses, in adults undergoing elective spine surgery.
  • The exposure was documented preoperative or perioperative GLP-1 receptor agonist use, assessed against fusion, infection, readmission, complications, and length of stay.
  • Lumbar fusion studies generally reported favorable or neutral associations, though some TLIF cohorts reported adverse ones, while cervical findings varied by surgical approach.
  • No included study reported postoperative pancreatitis, and the authors stress that the findings are associations and that perioperative management should be individualized.
PubMed indexed 14 Oct 2026 Imported 9 Nov 2026 Ferraz VR et al. Publisher NeuroPerioperative medicine
Observational Pain Physician Published Sep 2026 (day not reported)
Hormonal and Mental Health Influences on Musculoskeletal Pain and Mastalgia in Physically Active Women.
AI-generated abstract summary · verify against the original paper
  • Cross-sectional study of 20 healthy, physically active, full-busted women assigned female at birth, recruited at a university research center in Houston.
  • Self-reported neck, back, arm pain and mastalgia were compared with estradiol, progesterone, glycated hemoglobin, anthropometric measures, and mental health indicators.
  • Musculoskeletal pain, anxiety, and depression were reported as significant (P < 0.005), and estradiol, progesterone, and glycated hemoglobin were significantly associated with pain, though no effect sizes are given.
  • The authors conclude that hormonal and metabolic health influence pain and that covariates such as self-reported anxiety should be considered when examining pain mechanisms.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Yazdekhasti S et al. Chronic pain
Article Pain Physician Published Sep 2026 (day not reported)
Reduction of Serum Substance P and Beta Endorphin in Herpes Zoster After Erector Spinae Plane Block.
AI-generated abstract summary · verify against the original paper
  • Prospective, nonrandomized case-control study comparing herpes zoster patients with healthy age- and sex-matched volunteers; the sample size is not stated in the abstract.
  • Patients received an ultrasound-guided erector spinae plane block at the affected dermatome, with serum sampled before and after blocks.
  • IL-6 and substance P/CGRP levels did not differ significantly between herpes zoster patients and controls.
  • The authors report a significant post-block change (P = 0.009) in substance P and beta-endorphin, but the listed medians (24.0 and 237.8 after, 30.6 before) do not clearly match a decrease.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Lee JY et al. Chronic painRegional
Observational Pain Physician Published Sep 2026 (day not reported)
Morphometric Analysis of the Corpus Callosum in Relation to Adult Migraine: Association with Disease Duration and Clinical Disability.
AI-generated abstract summary · verify against the original paper
  • This single-center cross-sectional study compared 101 adults with migraine against 101 age- and sex-matched controls using midsagittal FLAIR MRI.
  • Corpus callosum genu, truncus, splenium thickness and length were measured by Witelson segmentation, then correlated with clinical measures within the migraine group.
  • Migraine patients had thinner genu (10.41 vs 11.43 mm), truncus (5.91 vs 6.68 mm), and splenium (10.73 vs 11.13 mm), all P < 0.05, with no length difference.
  • Genu thickness correlated with age at onset (r = 0.33), disability score (r = 0.37), and disease duration (r = -0.30), while attack frequency showed no association; the authors interpret this as cumulative remodeling.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Ozturk P et al. Chronic pain
Article Pain Physician Published Sep 2026 (day not reported)
Minimally Invasive Office-Based Protocol Yields Preliminary Improvements in Pelvic Pain and Function.
AI-generated abstract summary · verify against the original paper
  • A retrospective cohort of 2,660 patients with chronic pelvic pain at Pelvic Rehabilitation Medicine centers across the United States, compared at baseline and about 3 months.
  • The protocol was a series of six ultrasound-guided pelvic peripheral nerve blocks and trigger point injections, evaluated without a control group.
  • Pain fell 48.6% (P < 0.001), 55% reached at least 50% pain improvement, and opioid use fell 45.4%, with ED and urgent care visits down 89.4%.
  • The authors conclude the protocol is associated with broad improvements and call for longer-term follow-up against a control group.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Shirkhande A et al. Chronic painRegional
Article Pain Physician Published Sep 2026 (day not reported)
Evolution and Emerging Trends in Liposomal Bupivacaine Research: A Comprehensive Bibliometric Study (1993-2024).
AI-generated abstract summary · verify against the original paper
  • Bibliometric analysis of 580 Web of Science Core Collection publications on liposomal bupivacaine from 1993 through 2024, using VOSviewer, CiteSpace, and R.
  • The study maps publication trends, country, institution, journal, and author collaborations, and emerging research themes rather than comparing a treatment with a control.
  • Publications grew at an annual rate of 13.59%, with the United States leading (457 publications, 8,880 citations) and five research hotspots identified by cluster analysis.
  • The authors conclude research has shifted from basic pharmaceutical development toward clinical integration in enhanced recovery protocols, and call for comparative effectiveness and cost-benefit studies.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Wan X et al. Chronic pain
Observational Pain Physician Published Sep 2026 (day not reported)
Effects of Burst Spinal Cord Stimulation Versus Those of Paravertebral Block on Thoracic Subacute Herpetic Neuralgia: A Propensity Score-Matched Retrospective Cohort Study.
AI-generated abstract summary · verify against the original paper
  • Single-center retrospective cohort of 382 patients with thoracic subacute herpetic neuralgia, propensity-matched into 72 pairs of burst-SCS and thoracic paravertebral block recipients.
  • Burst spinal cord stimulation was compared with thoracic paravertebral block on pain, breakthrough pain, touch-evoked pain, sleep, and medication use over 12 months.
  • Burst-SCS showed greater VAS improvement from discharge through 12 months, higher cure rates, and lower postherpetic neuralgia incidence at 3 months, though the abstract gives no effect sizes or CIs.
  • Both procedures relieved pain and improved sleep, and the authors conclude burst-SCS had more favorable outcomes, with no difference in oral morphine equivalent dose.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Zhou XK et al. Chronic painRegional
Article Pain Physician Published Sep 2026 (day not reported)
Predictors of Treatment Success After Intercostal Nerve Radiofrequency for Intercostal Neuralgia: A Retrospective.
AI-generated abstract summary · verify against the original paper
  • Retrospective single-center chart review of 60 adults with post-traumatic, postherpetic, or idiopathic intercostal neuralgia treated with ultrasound-guided radiofrequency between 2018 and 2025.
  • Compared conventional radiofrequency ablation (n = 31) with pulsed radiofrequency (n = 29) on the intercostal nerves, with NRS pain scores at baseline, 3, and 6 months.
  • Mean NRS scores were lower with conventional ablation at 3 months (2.77 vs 5.83) and 6 months (2.81 vs 6.31), both P < 0.001.
  • In multivariable analysis, radiofrequency modality was the only independent predictor of 6-month response (OR 9.395; 95% CI 2.363-37.359; P = 0.001), and the authors conclude conventional ablation gave more sustained relief.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Yavuz K et al. Chronic pain
Observational Pain Physician Published Sep 2026 (day not reported)
Comparative Outcomes of Posterior and Lateral Sacroiliac Joint Fusions from a Single Academic Pain Center.
AI-generated abstract summary · verify against the original paper
  • A retrospective cohort of 80 patients at a single academic pain center compared posterior interpositional (n=33) and lateral transiliac (n=47) SI joint fusion performed from 2020 to 2025.
  • Both approaches were performed by interventional pain physicians, and the study compared short-term pain scores, blood loss, complications, and revision surgery between them.
  • Both groups improved mean VAS from 6.6 cm to 3.4 cm at one month, but revision for loss of efficacy was 18.2% for posterior versus 0% for lateral (P = 0.003).
  • The authors reported low blood loss and complication rates for both approaches and called for prospective, adequately powered studies to define long-term outcomes.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Mallard CJ et al. Chronic painNeuro
Observational Pain Physician Published Sep 2026 (day not reported)
Comparative Effectiveness of Intra-Articular Nanofat and Platelet-Rich Plasma Injections in Pain Relief and Functional Improvement for Unilateral Knee Osteoarthritis: A Retrospective Cohort Study.
AI-generated abstract summary · verify against the original paper
  • Retrospective cohort of 149 patients with predominantly unilateral knee OA at a tertiary pain clinic in India, treated July 2023 to August 2025 and followed for 6 months.
  • Compared intra-articular PRP (n=92) with nanofat (n=57), using NPRS pain scores and the 6-minute walk test measured via the Accupedo app.
  • Nanofat gave greater, sustained pain relief (P < 0.01) and functional gain (P = 0.006) than PRP; ≥50% relief odds were non-significant (adjusted OR 2.05, 95% CI 0.92 to 4.58).
  • Authors conclude nanofat gives greater, longer-lasting benefit but call for randomized trials, and link baseline varus deformity ≥5° to lower odds of significant pain relief.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Jain A et al. Chronic pain
Article Pain Physician Published Sep 2026 (day not reported)
Prediction of Therapeutic Outcome after Transforaminal Epidural Steroid Injection in Patients with Radiculopathy following Lumbar Spinal Stenosis Using Machine Learning.
AI-generated abstract summary · verify against the original paper
  • Retrospective single-center study of 188 patients with lumbar spinal stenosis who received a single-level transforaminal epidural steroid injection.
  • Three machine learning models (deep learning network, XGBoost, CatBoost) used nine clinical and MRI-derived variables to predict a ≥50% NRS reduction at one month.
  • The deep learning model had the best validation accuracy (0.868) and AUC (0.882, 95% CI, 0.733-0.994), versus CatBoost (AUC 0.765) and XGBoost (AUC 0.662).
  • The authors conclude deep learning outperformed conventional algorithms, but they call for larger multicenter studies for external validation before clinical use.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Kim JK et al. Chronic pain
RCT Pain Physician Published Sep 2026 (day not reported)
Comparative Effectiveness of Nucleoplasty and Intradiscal Ozone Therapy for Lumbar Disc Herniation: A Double-Blind, Randomized, Controlled Trial.
AI-generated abstract summary · verify against the original paper
  • Randomized, double-blind trial of 90 patients with lumbar disc herniation at a tertiary care center.
  • Compared intradiscal ozone therapy with percutaneous lumbar nucleoplasty, assessing pain (VAS), disability (ODI), and quality of life (SF-36) at baseline, 1 month, and 12 months.
  • Both groups improved significantly on VAS and ODI at 1 and 12 months (P < 0.001), with nucleoplasty showing lower scores than ozone at both time points.
  • The authors conclude both procedures are effective and that nucleoplasty has superior long-term outcomes, though the abstract reports no effect sizes or confidence intervals.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Kilic M et al. Chronic pain
RCT Pain Physician Published Sep 2026 (day not reported)
Ultrasound- and Fluoroscopy-Guided Curved Needle Lumbar Sympathetic Radiofrequency Ablation for Diabetic Peripheral Neuropathy Pain: A Randomized Trial.
AI-generated abstract summary · verify against the original paper
  • Randomized trial of 60 patients with diabetic peripheral neuropathic pain at one hospital in China, split into curved-needle (n=30) and straight-needle (n=30) lumbar sympathetic radiofrequency ablation groups.
  • The comparison was curved-needle versus straight-needle technique for lumbar sympathetic ganglion radiofrequency ablation, both guided by ultrasound and fluoroscopy and combined with anhydrous ethanol.
  • The curved needle group had shorter procedure time (10.6 ± 3.1 vs 15.2 ± 2.3 min, P < 0.001), fewer needle redirections (0.5 vs 4.5) and fewer bone contacts (1.0 vs 4.0), all P < 0.001.
  • Success rate (96.7% vs 90.0%, P = 0.611), VAS pain scores and complications (3.33% vs 13.33%, P = 0.357) did not differ significantly, and the authors report higher satisfaction with the curved needle.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Wang M et al. Chronic pain
RCT Pain Physician Published Sep 2026 (day not reported)
Prolozone M Therapy's Analgesic Efficacy for Managing Moderate-to-Severe Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial.
AI-generated abstract summary · verify against the original paper
  • Randomized, double-blind, placebo-controlled trial of 180 patients with moderate-to-severe knee osteoarthritis (Kellgren-Lawrence 3 or 4) at a single Indian tertiary pain clinic.
  • Patients received three intraarticular injections, every 3 weeks, of hypertonic dextrose, ozone, and magnesium (Prolozone M), compared with corticosteroid or saline.
  • At 24 weeks, WOMAC pain improved more than with corticosteroid (mean change -2.3, 98.3% CI -3.8 to -0.8, P<0.001, d 0.88); saline comparison is not reported in the abstract.
  • The authors conclude the therapy is safe and provides clinically relevant analgesia, with early signs of chondroprotection on radiographs.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Niraj G et al. Chronic pain
Article Pain Physician Published Sep 2026 (day not reported)
Analgesic Efficacy of Mirogabalin in Patients With Herpes Zoster: Protocol for a Prospective Multicenter Randomized Open-Label Blinded-Endpoint (PROBE) Study.
AI-generated abstract summary · verify against the original paper
  • Protocol for a planned multicenter, randomized, open-label, blinded-endpoint trial of 750 adults with moderate-to-severe herpes zoster pain and rash onset within 30 days.
  • Participants will be randomized 1:1 to conventional treatment plus oral mirogabalin, titrated from 5 mg to 15 mg twice daily, or conventional treatment alone.
  • No results are reported; the primary outcome is average pain intensity at week 4, with secondary outcomes including postherpetic neuralgia incidence and adverse events.
  • The authors hypothesize that adding mirogabalin gives superior pain relief, to be tested over a 52-week follow-up.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Xing Y et al. Chronic pain
RCT Pain Physician Published Sep 2026 (day not reported)
The Effect of Unilateral Subcostal Transversus Abdominis Plane Block Applied as Single or Multiple Injections on Pain in Laparoscopic Cholecystectomy.
AI-generated abstract summary · verify against the original paper
  • Prospective, randomized, single-center trial of 90 adults (89 completed) undergoing elective laparoscopic cholecystectomy, allocated to single-injection, multi-injection, or no-block groups.
  • Ultrasound-guided unilateral subcostal TAP block was given as a single injection or as multiple injections, compared with no block.
  • The multi-injection group had the lowest 24-hour tramadol use and lower VAS scores at 1, 6, and 24 hours (P<0.05), with PONV-free rates of 92% vs 64% vs 52% (P=0.007).
  • The authors conclude both block types gave effective analgesia, with the multi-injection technique showing superior pain control and higher patient satisfaction (P<0.001).
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Nihan OMG et al. Chronic painRegional
RCT Pain Physician Published Sep 2026 (day not reported)
Comparison of the Effects of Normal Saline, Hypertonic Saline, and Hyaluronidase on Patients with Postoperative Relapse of Carpal Tunnel Syndrome: A Randomized Controlled Trial.
AI-generated abstract summary · verify against the original paper
  • A single-center randomized controlled trial in Iran enrolled 90 patients with carpal tunnel relapse after surgery, split into three groups of 30 and followed for 12 months.
  • Patients received ultrasound-guided hydrodissection with hyaluronidase 300 IU, hypertonic saline 5%, or normal saline, each combined with methylprednisolone and bupivacaine.
  • All groups improved, but the hyaluronidase group had significantly greater reductions in VAS and Symptom Severity Scale scores at every follow-up (P < 0.01).
  • Hyaluronidase also required fewer reinjections and reported the highest satisfaction, while hypertonic and normal saline did not differ significantly.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Shahrezaee M et al. Chronic painPediatric
Review Pain Physician Published Sep 2026 (day not reported)
Perioperative Management of Antiplatelet and Anticoagulant Therapy in Patients Undergoing Interventional Techniques: A Critical and Analytical Summary of the 2024 Guidelines of the American Society of Interventional Pain Physicians (ASIPP).
AI-generated abstract summary · verify against the original paper
  • This is a structured critical review of the 2024 ASIPP consensus guideline, built from literature review, evidence synthesis, and modified Delphi voting.
  • It summarizes recommendations on stopping, bridging, and resuming antiplatelet and anticoagulant drugs, with 50 interventional procedures stratified by composite risk score.
  • Of the 50 procedures, 19 were classed low-risk, 7 moderate-risk, and 24 high-risk, and 16 of 18 recommendations reached unanimous panel acceptance.
  • The authors favor selective rather than routine cessation, especially for low-risk procedures, while acknowledging uncertainty about procedure classifications and interruption intervals.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Manchikanti L et al. Chronic painPerioperative medicine
Meta-analysis Pain Physician Published Sep 2026 (day not reported)
An Updated Systematic Review and Meta-Analysis of Fluoroscopic Caudal, Interlaminar, and Transforaminal Epidural Injections in Lumbar Disc Herniation.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of 21 fluoroscopically guided RCTs on caudal, transforaminal, and interlaminar epidural injections for lumbar disc herniation, searching 2020 to March 2026.
  • Trials compared local anesthetic with steroid against local anesthetic alone, or against placebo or an active control.
  • Best-evidence synthesis graded local anesthetic with steroid as Level I for transforaminal and interlaminar injections and Level II for local anesthetic alone; caudal injections reached Level II for both. The abstract reports no pooled effect sizes or CIs.
  • Authors note that few studies reported outcomes of at least 6 months, and that conventional dual-arm meta-analysis was feasible only for interlaminar injections.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Manchikanti L et al. Chronic pain
Guideline Pain Physician Published Sep 2026 (day not reported)
Regenerative Therapies in the Management of Chronic Low Back Pain from Evidence to Practice: An Analytical Summary of the 2025 Comprehensive Evidence-Based Guidelines.
AI-generated abstract summary · verify against the original paper
  • This 2025 ASIPP guideline summary on regenerative therapies for chronic low back pain used systematic review, GRADE appraisal, and a modified Delphi process with 33 voting panelists.
  • Evidence was graded by target: lumbar intradiscal and epidural PRP and intradiscal BMAC were rated Level III, while facet and sacroiliac PRP or MSC injections were rated Level IV.
  • All 19 recommendations reached 100% panel agreement; lumbar intradiscal and epidural biologics received moderate recommendations, while sacroiliac PRP and multitarget injections received low ones.
  • The authors condition all lumbar biologic recommendations on definitive diagnosis, failed conservative care, FDA regulatory adherence, injectate verification, and consent covering experimental status and out-of-pocket cost.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Manchikanti L et al. Chronic pain
Meta-analysis Pain Physician Published Sep 2026 (day not reported)
Translating Evidence to Practice: A Critical and Analytical Summary of the Evidence-Based Guidelines of Facet Joint Interventions in Management of Chronic Spinal Pain.
AI-generated abstract summary · verify against the original paper
  • This is a guideline summary combining a systematic literature review from 1966 to October 2025, GRADE appraisal, and modified Delphi consensus on facet joint interventions for chronic axial spinal pain.
  • It covers controlled diagnostic medial branch blocks and therapeutic options, including radiofrequency ablation, facet nerve blocks, and intraarticular injections, across the cervical, thoracic, and lumbar spine.
  • Diagnostic medial branch blocks use an 80% pain-relief threshold with moderate to strong recommendations, while cervical and lumbar RFA and therapeutic nerve blocks in all regions received moderate recommendations at Level II evidence.
  • Cost-utility estimates were $4,664 to $5,446 per QALY for lumbar and $4,994 to $5,364 for cervical interventions, and the authors call for more thoracic, intraarticular, and comparative research.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Manchikanti L et al. Chronic pain
Review Pain Physician Published Sep 2026 (day not reported)
Macrophages of CNS and DRG in Postherpetic Neuralgia: From Pathobiology to Therapeutic Frontiers.
AI-generated abstract summary · verify against the original paper
  • This is a narrative review of PubMed literature on macrophage mechanisms in the CNS and DRG in postherpetic neuralgia, with no primary data.
  • It identifies microglial activation in the spinal dorsal horn and macrophage expansion in the DRG as major proposed mechanisms underlying PHN.
  • Symptomatic treatments reviewed include medications, nerve blocks, and neuromodulation, while etiological approaches focus on autologous biomaterials such as fat, BMAC, plasma, and serum.
  • The authors note that autologous biomaterial therapies lack multicenter, large-sample, high-quality studies, and they call for better interventions for refractory PHN.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Luo T et al. Chronic pain
Review Pain Physician Published Sep 2026 (day not reported)
Spinal Cord Stimulation for the Treatment of Phantom Limb Pain: A Narrative Review.
AI-generated abstract summary · verify against the original paper
  • This narrative review pooled 9 case report and case series articles, covering 27 amputees treated with spinal cord stimulation for pain-related symptoms.
  • The review compared no alternative treatment; it examined SCS as the intervention for phantom limb pain across upper and lower limb amputations.
  • Combined pain scores fell by a mean of 60.1% (SD 27.6), and only one included study assessed function before and after surgery.
  • The authors conclude SCS appears to be a favorable option for phantom limb pain and may have a role in somatosensory feedback.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Fawaz R et al. Chronic pain
Review Pain Physician Published Sep 2026 (day not reported)
Practice Expense, Site of Service, and the Survival of the Independent Interventional Pain Practices: With Medicare Policies Leading the Way.
AI-generated abstract summary · verify against the original paper
  • This narrative health policy review synthesizes the CY 2026 final rule, CY 2027 proposed rule, and Medicare cost and utilization data, without patient-level data or statistical testing.
  • It examines the CY 2026 rule's cut in indirect practice expense for facility services to 50% of the non-facility amount.
  • Inflation-adjusted Medicare payment fell about 41% in interventional pain management from 2001 to 2025, while practice costs rose 59% by the Medicare Economic Index.
  • The authors argue the facility/non-facility split poorly captures who bears indirect costs and propose an independent-practice modifier instead.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Manchikanti L et al. Chronic pain
Article Pain Physician Published Sep 2026 (day not reported)
The Escalating Growth of Spending on Medicare Advantage Plans: A 2026 Update on Controlling Costs, Preserving Medicare Solvency, and Balancing the Federal Budget.
AI-generated abstract summary · verify against the original paper
  • Narrative update of a 2025 analysis, drawing on Medicare Trustees, MedPAC, CMS and CRFB sources through August 2026; no primary data are presented.
  • Reports Medicare Advantage projected to cost $615 billion in 2026, about 14% ($76 billion) above equivalent fee-for-service spending, with coding intensity estimated at 10.3%.
  • Notes that a September 2025 court ruling barred extrapolating RADV audit findings across whole contracts, and cites CRFB projections of $1.2 to $1.3 trillion in MA overpayments over 2026-2035.
  • Concludes that reforms have been partly offset by litigation and incomplete implementation, and that prior-authorization burden is migrating into traditional Medicare for interventional pain procedures.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Manchikanti L et al. Chronic pain
Review Pain Physician Published Sep 2026 (day not reported)
Ambulatory Surgery Centers and Medicare Payment Policy for Calendar Year 2027: Impact on Interventional Pain Management.
AI-generated abstract summary · verify against the original paper
  • This narrative policy review examines the CY 2027 OPPS/ASC proposed rule (CMS-1850-P) and prior Pain Physician analyses, focused on interventional pain management.
  • Alongside a 2.4% ASC update, neuromodulation codes such as SCS generator insertion (+14.8%) get large proposed increases, but multiple-procedure discounts may offset them.
  • Core injection-based procedures, including epidural steroid injections, facet joint injections, and facet radiofrequency ablation, are proposed to decrease by 3.8% to 4.3%.
  • The authors conclude the proposed trajectory favors device-based procedures in ASCs over hospital outpatient departments, while injection-based services face compounding erosion in relative payment.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Manchikanti L et al. Chronic pain
Observational Pain Physician Published Sep 2026 (day not reported)
Real-World Safety Profile of Intrathecal Morphine Monotherapy vs Morphine-Bupivacaine Combination: A 10-Year MAUDE Database Analysis.
AI-generated abstract summary · verify against the original paper
  • Retrospective analysis of FDA MAUDE adverse event reports from 2016 to 2025 for SynchroMed and Prometra intrathecal pumps, with 5,423 morphine-only and 1,072 morphine-bupivacaine reports.
  • Compares intrathecal morphine monotherapy with a binary morphine-bupivacaine mixture, looking at dosing and device- and medication-related adverse events.
  • The binary group received a higher median morphine dose (2.20 vs 1.50 mg/day) yet had less cognitive impairment (0.56% vs 1.48%, P < 0.05); granulomas trended lower (0.65% vs 1.33%, P = 0.068).
  • The authors conclude that adding bupivacaine gives a safety profile similar to morphine alone, with less cognitive impairment and a trend toward fewer granulomas.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Mantilla-Santamaria AF et al. Chronic pain
Review Pain Physician Published Sep 2026 (day not reported)
Implications of the CMS Ambulatory Specialty Model for Low Back Pain for Interventional Pain Management: The Good, The Bad, And The Ugly.
AI-generated abstract summary · verify against the original paper
  • Narrative policy review of CMS's Ambulatory Specialty Model, a mandatory payment model covering heart failure and low back pain, with no study population or sample size reported.
  • The review describes ASM's physician selection, episode-based cost adjustments by site of service, quality and PROM requirements, and Collaborative Care Arrangement rules, comparing it with MIPS and ACOs.
  • The abstract reports no quantitative results; instead it weighs whether ASM is a carrot-and-stick or aversion-based policy and whether it represents innovation or limitation.
  • It focuses on implications for interventional pain management, including comparisons across specialties such as neurosurgery and pain medicine, and ends with a practical action list for practices.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Manchikanti L et al. Chronic pain
Article Pain Physician Published Sep 2026 (day not reported)
Peripheral Nerve Stimulation for Intractable Chronic Pain: Real-World Clinical Outcomes, Utilization, and Economic Impact (PNS IMPACT Study).
AI-generated abstract summary · verify against the original paper
  • Hybrid retrospective study of 175 adults with chronic neuropathic pain at one US center, plus national claims data (n = 953).
  • Patients had a PNS trial, and those with at least 50% relief could receive permanent implants; outcomes were compared with baseline, not a control group.
  • Mean NRS-11 pain fell from 7.2 at baseline to 1.7 at 12 months, 1.4 at 24 months, and 2.2 at 36 months (all P < 0.001), with no serious adverse events reported.
  • Pain center office visits fell 54.1% in months 0-12 and 58.9% in months 13-24, with two-year cost reductions totaling $10,271.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Moghim R et al. Chronic painRegional
Article Pain Physician Published Sep 2026 (day not reported)
The CY 2027 Medicare Physician Fee Schedule and the Continuing Struggle to Balance Cost, Quality, Access, and the Survival of Interventional Pain Management.
AI-generated abstract summary · verify against the original paper
  • This policy analysis reviews the CY 2027 Medicare Physician Fee Schedule Proposed Rule alongside the prior final rule, CMS-related reports, and peer-reviewed literature.
  • It examines the proposed efficiency adjustment, practice expense redesign, and mandatory Ambulatory Specialty Model as they affect independent interventional pain practices.
  • The projected qualifying-APM conversion factor is $33.1693, down $0.42 (-1.19%) from CY 2026, and most interventional pain procedures face further cuts of roughly 2% to 6%.
  • The authors conclude the rule widens the gap between practice costs and procedural payment, and they recommend inflation-indexed updates, rule revisions, and a distinct identifier for independent physicians.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Manchikanti L et al. Chronic pain
Article Pain Physician Published Sep 2026 (day not reported)
Local Coverage Determinations for Peripheral Nerve Injections and Procedures for Chronic Pain: Policy Changes, Clinical Limitations, and Health-Equity Implications.
AI-generated abstract summary · verify against the original paper
  • This health-policy analysis compares September 2025 draft Medicare LCDs for peripheral nerve injections in chronic pain with the final policies, and examines their equity implications.
  • The draft policies would have limited coverage mainly to trigeminal neuralgia radiofrequency and certain corticosteroid injections, with lifetime caps; the final policies restored criteria-based coverage for several blocks.
  • Four contractors published materially identical final LCDs, effective October 25, 2026, while participation in the collaborative process was reported separately from final publication.
  • Pudendal, intercostal, ganglion impar, ulnar, and other peripheral-nerve procedures remain noncovered for chronic pain, and the authors highlight access implications of geographically discordant coverage.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Soin A et al. Chronic painRegional
Article J Cardiothorac Vasc Anesth Published 1 Sep 2026
Long-Term Outcomes of Ultrasound-Guided Percutaneous Bilateral Cardiac Sympathetic Denervation in Patients With Refractory Arrhythmic Storm: A Prospective Cohort Study.
AI-generated abstract summary · verify against the original paper
  • Prospective single-center observational cohort of 18 consecutive patients with refractory electrical storm, of whom 15 completed follow-up.
  • Patients received ultrasound-guided percutaneous stellate ganglion block and bilateral cardiac sympathetic denervation, with two radiofrequency lesions followed by levobupivacaine infiltration; no comparator group was used.
  • Median sustained ventricular arrhythmias fell from 4 at baseline to 0 at 3 months (p<0.01) and were 1.5 at 12 months (p=0.05).
  • Transient Horner syndrome occurred in 73% of patients, and the authors conclude that BCSD is safe and effective, with a 12-month overall survival of 58%.
PubMed indexed 22 Sep 2026 Imported 9 Nov 2026 López González JM et al. Publisher CardiacChronic pain
Review Pain Published 1 Sep 2026
Quantifying nociceptive state across the neuraxis with in vivo fiber photometry: methodological foundations, constraints, and future directions.
AI-generated abstract summary · verify against the original paper
  • This is a methodological review of in vivo fiber photometry for measuring nociceptive state across the brain and spinal cord in rodent models.
  • It weighs the advantages of longitudinal, cell-type-specific recording during free movement against systematic error sources that are amplified in pain paradigms.
  • Key constraints include a heterogeneous sampling volume, somatic-neuropil signal mixing, indicator kinetics that blur spiking, and motion, photobleaching, or hemodynamic artifacts that can mimic neural responses.
  • The authors stress reference channels, artifact correction, behavioral alignment, and transparent reporting, and flag the parabrachial nucleus, periaqueductal gray, and anterior cingulate cortex as targets.
PubMed indexed 17 Sep 2026 Imported 9 Nov 2026 Miah MH et al. Publisher Chronic pain
Newer Older